Tag: licensing
-
Device Measuring Nerves on Heart Rhythm in Development
22 July 2016. A spin-off enterprise from Indiana University is creating a device to measure sympathetic nerve activity — the fight-or-flight response — in people with heart rhythm disorders. Research and development of a prototype device, by Arrhythmotech LLC in Indianapolis, is funded by a new 2-year, $1.47 million grant from National Institute of Drug…
-
Nanotech Imaging Start-Up Raises $3M in Seed Financing
A spin-off enterprise from University of California-Berkeley, developing an imaging technology with magnetic nanoparticles, is raising $3 million in funding.
-
Refillable HIV Prevention Implant in Development
A device implanted under the skin providing 60 days of antiretroviral drugs to prevent HIV infection is in development at Houston Methodist Research Institute.
-
RNA Technology Licensed for Cystic Fibrosis Therapy
Two biotechnology companies are collaborating on treatments for cystic fibrosis that use genetic material to address underlying causes of the inherited disease.
-
Bacterial-Biopolymer Delivery System Designed for Vaccines
A biotechnology company and university lab developed a vaccine delivery technique that induces an immune response, combining bacteria and a polymer material.
-
Protein Biotech Lands $51.5M in First Venture Round
A spin-off enterprise from Harvard developing therapies that block signaling proteins causing disease is raising $51.5 million its first venture funding round.
-
Moderna, Merck Partner on Personal Cancer Vaccines
29 June 2016. Biotechnology company Moderna Therapeutics and drug maker Merck are developing therapeutic vaccines using messenger RNA that address unique genetic patterns in patients’ tumors. The deal is expected to bring Moderna an immediate payment of $200 million, and the chance to earn further payments to develop cancer treatments combining Moderna’s technology with an…
-
App Evaluates Chest Pain Patients for Discharge
A new iPhone app helps emergency physicians decide whether a patient with chest pain can be safely discharged from a hospital or needs further tests.
-
Celgene, Medical Centers to Partner on Cancer Therapies
Biopharmaceutical company Celgene Corp. and a consortium of four medical research institutes are collaborating on new diagnostics and treatments for cancer.
-
FDA Approves Cholera Vaccine
13 June 2016. Food and Drug Administration approved for marketing the U.S. a vaccine to prevent cholera for travelers to regions in the world where contaminated food or water is causing the disease. Vaxchora by PaxVax Inc. in Redwood City, California is the first vaccine approved by the agency to prevent cholera. According to World…